DE69916493D1 - Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom - Google Patents

Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom

Info

Publication number
DE69916493D1
DE69916493D1 DE69916493T DE69916493T DE69916493D1 DE 69916493 D1 DE69916493 D1 DE 69916493D1 DE 69916493 T DE69916493 T DE 69916493T DE 69916493 T DE69916493 T DE 69916493T DE 69916493 D1 DE69916493 D1 DE 69916493D1
Authority
DE
Germany
Prior art keywords
protein
treatment
hemolytic
purpura
thrombozytopenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69916493T
Other languages
English (en)
Other versions
DE69916493T2 (de
Inventor
Jack Fisher
Betty Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69916493D1 publication Critical patent/DE69916493D1/de
Publication of DE69916493T2 publication Critical patent/DE69916493T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69916493T 1998-12-10 1999-12-01 Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom Expired - Fee Related DE69916493T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11177098P 1998-12-10 1998-12-10
US111770P 1998-12-10
PCT/US1999/028433 WO2000033867A1 (en) 1998-12-10 1999-12-01 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome

Publications (2)

Publication Number Publication Date
DE69916493D1 true DE69916493D1 (de) 2004-05-19
DE69916493T2 DE69916493T2 (de) 2005-03-24

Family

ID=22340356

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916493T Expired - Fee Related DE69916493T2 (de) 1998-12-10 1999-12-01 Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom

Country Status (13)

Country Link
US (2) US20010003740A1 (de)
EP (1) EP1137432B1 (de)
JP (1) JP2002531519A (de)
CN (1) CN1329503A (de)
AT (1) ATE264113T1 (de)
AU (1) AU1838500A (de)
BR (1) BR9915984A (de)
CA (1) CA2351555A1 (de)
DE (1) DE69916493T2 (de)
ES (1) ES2219094T3 (de)
IL (1) IL142249A0 (de)
WO (1) WO2000033867A1 (de)
ZA (1) ZA200102730B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002028416A1 (ja) * 2000-09-30 2004-02-12 持田製薬株式会社 溶血性貧血の予防・治療剤
CA2668187A1 (en) * 2006-10-31 2008-06-19 The Scripps Research Institute Dosing regimen of activated protein c and variants having reduced anticoagulant activity
CN105833255A (zh) * 2016-03-23 2016-08-10 兆科药业（合肥）有限公司 抗血小板溶栓素在制备治疗血栓性血小板减少性紫癜的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
ID22933A (id) * 1997-04-28 1999-12-16 Lilly Co Eli Fomulasi protien c terakivasi

Also Published As

Publication number Publication date
US20040087643A1 (en) 2004-05-06
BR9915984A (pt) 2001-09-04
US20010003740A1 (en) 2001-06-14
ZA200102730B (en) 2002-07-03
DE69916493T2 (de) 2005-03-24
EP1137432A1 (de) 2001-10-04
ES2219094T3 (es) 2004-11-16
AU1838500A (en) 2000-06-26
EP1137432B1 (de) 2004-04-14
IL142249A0 (en) 2002-03-10
WO2000033867A1 (en) 2000-06-15
CN1329503A (zh) 2002-01-02
JP2002531519A (ja) 2002-09-24
ATE264113T1 (de) 2004-04-15
CA2351555A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
ATE234092T1 (de) 2-alkylpyrrolidine
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
NO963860L (no) Isoprenyl-transferase-inhibitorer
RS20060320A (en) Substituted indazole-o-glucosides
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
SG130189A1 (en) Substituted indole-o-glucosides
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
BG102644A (en) Improved concentrated inoculation and infusion solutions for intravasal application
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
WO2021195470A3 (en) Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2
ATE235915T1 (de) Behandlung von hämorrhagischem virusfieber mit protein c
DE69916493D1 (de) Verwendung von protein c zur behandlung von thrombozytopenischer purpura und hämolytisches urämisches syndrom
ATE404208T1 (de) Uridin-therapie für patienten mit erhöhten purin- werten
NO980251L (no) Behandling av konsentrasjonssvikt/hyperaktivitetsforstyrrelse
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
DE69330465T2 (de) Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4-aza-5 alpha-androst-1-en-3-one
DE69905489D1 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
AU2001280093A1 (en) Method for the prevention and treatment of retinopathy
DE69930419D1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
GB0016362D0 (en) Tetraspanin modulation
ATE496939T1 (de) Methode zur reinigung von keratinozyten- wachstumfaktoren
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
DK0828483T3 (da) Anvendelse af tropolonderivater som inhibitorer af enzymet inositolmonophosphatase
NO984190L (no) FremgangsmÕte for behandling av insomnia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee